SARS-COV-2 Vaccinations in RMD patients
The EULAR Task Force on COVID-19 has updated the EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs (December 2021).
The information addresses questions, including considerations regarding vaccination effectiveness and safety, the third vaccination dose, booster vaccination, combination with Influenza and Pneumococcus vaccination, among other frequently asked questions by people with RMDs.
EULAR President, Prof Annamaria Iagnocco, invites you to share the link with your axSpA community.
Other NEWS
Watch On Demand: “Not Just Back Pain – Patient Experiences” Webinar in Spanish
The Ankylosing Spondylitis Foundation in Colombia recently hosted an informative …
Read More
Making Access Happen – Sandoz Global Access Forum 2026
Prachee Bhosle The Global Access Forum by Making Access Happen, organised …
Read More
Exploring the Value of Remission during the World Health Assembly
During the 79th World Health Assembly in Geneva, Jo Davies …
Read More